Global Onychomycosis (Tinea Unguium) Drug Market Growth 2020-2025
According to this study, over the next five years the Onychomycosis (Tinea Unguium) Drug market will register a 3.2%% CAGR in terms of revenue, the global market size will reach $ 3282.3 million by 2025, from $ 2892 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Onychomycosis (Tinea Unguium) Drug business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Onychomycosis (Tinea Unguium) Drug market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Onychomycosis (Tinea Unguium) Drug, covering the supply chain analysis, impact assessment to the Onychomycosis (Tinea Unguium) Drug market size growth rate in several scenarios, and the measures to be undertaken by Onychomycosis (Tinea Unguium) Drug companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Oral Medication
External Medicine
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Age under 18
Age 18-50
Age above 50
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Johnson and Johnson
Qilu Pharmaceutical
GSK
Pfizer
Valeant Pharma
Novartis
Xiuzheng Pharmaceutical
Kaken Pharmaceutical
Letai
Galderma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Onychomycosis (Tinea Unguium) Drug consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Onychomycosis (Tinea Unguium) Drug market by identifying its various subsegments.
Focuses on the key global Onychomycosis (Tinea Unguium) Drug manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Onychomycosis (Tinea Unguium) Drug with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Onychomycosis (Tinea Unguium) Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Onychomycosis (Tinea Unguium) Drug Consumption 2015-2025
2.1.2 Onychomycosis (Tinea Unguium) Drug Consumption CAGR by Region
2.2 Onychomycosis (Tinea Unguium) Drug Segment by Type
2.2.1 Oral Medication
2.2.2 External Medicine
2.3 Onychomycosis (Tinea Unguium) Drug Consumption by Type
2.3.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
2.3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue and Market Share by Type (2015-2020)
2.3.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2015-2020)
2.4 Onychomycosis (Tinea Unguium) Drug Segment by Application
2.4.1 Age under 18
2.4.2 Age 18-50
2.4.3 Age above 50
2.5 Onychomycosis (Tinea Unguium) Drug Consumption by Application
2.5.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
2.5.2 Global Onychomycosis (Tinea Unguium) Drug Value and Market Share by Type (2015-2020)
2.5.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2015-2020)
3 Global Onychomycosis (Tinea Unguium) Drug by Company
3.1 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company
3.1.1 Global Onychomycosis (Tinea Unguium) Drug Sales by Company (2018-2020)
3.1.2 Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2018-2020)
3.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company
3.2.1 Global Onychomycosis (Tinea Unguium) Drug Revenue by Company (2018-2020)
3.2.2 Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company (2018-2020)
3.3 Global Onychomycosis (Tinea Unguium) Drug Sale Price by Company
3.4 Global Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Onychomycosis (Tinea Unguium) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Onychomycosis (Tinea Unguium) Drug by Regions
4.1 Onychomycosis (Tinea Unguium) Drug by Regions
4.2 Americas Onychomycosis (Tinea Unguium) Drug Consumption Growth
4.3 APAC Onychomycosis (Tinea Unguium) Drug Consumption Growth
4.4 Europe Onychomycosis (Tinea Unguium) Drug Consumption Growth
4.5 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Growth
5 Americas
5.1 Americas Onychomycosis (Tinea Unguium) Drug Consumption by Countries
5.1.1 Americas Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2015-2020)
5.1.2 Americas Onychomycosis (Tinea Unguium) Drug Value by Countries (2015-2020)
5.2 Americas Onychomycosis (Tinea Unguium) Drug Consumption by Type
5.3 Americas Onychomycosis (Tinea Unguium) Drug Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Onychomycosis (Tinea Unguium) Drug Consumption by Regions
6.1.1 APAC Onychomycosis (Tinea Unguium) Drug Consumption by Regions (2015-2020)
6.1.2 APAC Onychomycosis (Tinea Unguium) Drug Value by Regions (2015-2020)
6.2 APAC Onychomycosis (Tinea Unguium) Drug Consumption by Type
6.3 APAC Onychomycosis (Tinea Unguium) Drug Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Onychomycosis (Tinea Unguium) Drug by Countries
7.1.1 Europe Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2015-2020)
7.1.2 Europe Onychomycosis (Tinea Unguium) Drug Value by Countries (2015-2020)
7.2 Europe Onychomycosis (Tinea Unguium) Drug Consumption by Type
7.3 Europe Onychomycosis (Tinea Unguium) Drug Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug by Countries
8.1.1 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value by Countries (2015-2020)
8.2 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Type
8.3 Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Onychomycosis (Tinea Unguium) Drug Distributors
10.3 Onychomycosis (Tinea Unguium) Drug Customer
11 Global Onychomycosis (Tinea Unguium) Drug Market Forecast
11.1 Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast (2021-2025)
11.2 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions
11.2.1 Global Onychomycosis (Tinea Unguium) Drug Forecast by Regions (2021-2025)
11.2.2 Global Onychomycosis (Tinea Unguium) Drug Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Onychomycosis (Tinea Unguium) Drug Forecast by Type
11.8 Global Onychomycosis (Tinea Unguium) Drug Forecast by Application
12 Key Players Analysis
12.1 Johnson and Johnson
12.1.1 Company Information
12.1.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.1.3 Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Johnson and Johnson Latest Developments
12.2 Qilu Pharmaceutical
12.2.1 Company Information
12.2.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.2.3 Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Qilu Pharmaceutical Latest Developments
12.3 GSK
12.3.1 Company Information
12.3.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.3.3 GSK Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 GSK Latest Developments
12.4 Pfizer
12.4.1 Company Information
12.4.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.4.3 Pfizer Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Pfizer Latest Developments
12.5 Valeant Pharma
12.5.1 Company Information
12.5.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.5.3 Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Valeant Pharma Latest Developments
12.6 Novartis
12.6.1 Company Information
12.6.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.6.3 Novartis Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Novartis Latest Developments
12.7 Xiuzheng Pharmaceutical
12.7.1 Company Information
12.7.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.7.3 Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Xiuzheng Pharmaceutical Latest Developments
12.8 Kaken Pharmaceutical
12.8.1 Company Information
12.8.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.8.3 Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Kaken Pharmaceutical Latest Developments
12.9 Letai
12.9.1 Company Information
12.9.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.9.3 Letai Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Letai Latest Developments
12.10 Galderma
12.10.1 Company Information
12.10.2 Onychomycosis (Tinea Unguium) Drug Product Offered
12.10.3 Galderma Onychomycosis (Tinea Unguium) Drug Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Galderma Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Onychomycosis (Tinea Unguium) Drug Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Oral Medication
Table 5. Major Players of External Medicine
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
Table 8. Global Onychomycosis (Tinea Unguium) Drug Revenue by Type (2015-2020) ($ million)
Table 9. Global Onychomycosis (Tinea Unguium) Drug Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application (2015-2020)
Table 13. Global Onychomycosis (Tinea Unguium) Drug Value by Application (2015-2020)
Table 14. Global Onychomycosis (Tinea Unguium) Drug Value Market Share by Application (2015-2020)
Table 15. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Application (2015-2020)
Table 16. Global Onychomycosis (Tinea Unguium) Drug Sales by Company (2017-2019) (K Units)
Table 17. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company (2017-2019)
Table 18. Global Onychomycosis (Tinea Unguium) Drug Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company (2017-2019)
Table 20. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Company (2017-2019)
Table 21. Global Onychomycosis (Tinea Unguium) Drug Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Onychomycosis (Tinea Unguium) Drug Products Offered
Table 23. Onychomycosis (Tinea Unguium) Drug Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Onychomycosis (Tinea Unguium) Drug Consumption by Regions 2015-2020 (K Units)
Table 25. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Regions 2015-2020
Table 26. Global Onychomycosis (Tinea Unguium) Drug Value by Regions 2015-2020 ($ Millions)
Table 27. Global Onychomycosis (Tinea Unguium) Drug Value Market Share by Regions 2015-2020
Table 28. Americas Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries (2015-2020)
Table 30. Americas Onychomycosis (Tinea Unguium) Drug Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Onychomycosis (Tinea Unguium) Drug Value Market Share by Countries (2015-2020)
Table 32. Americas Onychomycosis (Tinea Unguium) Drug Consumption by Type (2015-2020) (K Units)
Table 33. Americas Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
Table 34. Americas Onychomycosis (Tinea Unguium) Drug Consumption by Application (2015-2020) (K Units)
Table 35. Americas Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application (2015-2020)
Table 36. APAC Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries (2015-2020)
Table 38. APAC Onychomycosis (Tinea Unguium) Drug Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Onychomycosis (Tinea Unguium) Drug Value Market Share by Regions (2015-2020)
Table 40. APAC Onychomycosis (Tinea Unguium) Drug Consumption by Type (2015-2020) (K Units)
Table 41. APAC Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
Table 42. APAC Onychomycosis (Tinea Unguium) Drug Consumption by Application (2015-2020) (K Units)
Table 43. APAC Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application (2015-2020)
Table 44. Europe Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries (2015-2020)
Table 46. Europe Onychomycosis (Tinea Unguium) Drug Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Onychomycosis (Tinea Unguium) Drug Value Market Share by Countries (2015-2020)
Table 48. Europe Onychomycosis (Tinea Unguium) Drug Consumption by Type (2015-2020) (K Units)
Table 49. Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
Table 50. Europe Onychomycosis (Tinea Unguium) Drug Consumption by Application (2015-2020) (K Units)
Table 51. Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application (2015-2020)
Table 60. Onychomycosis (Tinea Unguium) Drug Distributors List
Table 61. Onychomycosis (Tinea Unguium) Drug Customer List
Table 62. Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Forecast by Regions
Table 64. Global Onychomycosis (Tinea Unguium) Drug Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Onychomycosis (Tinea Unguium) Drug Value Market Share Forecast by Regions
Table 66. Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Onychomycosis (Tinea Unguium) Drug Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Onychomycosis (Tinea Unguium) Drug Value Market Share Forecast by Type (2021-2025)
Table 70. Global Onychomycosis (Tinea Unguium) Drug Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Onychomycosis (Tinea Unguium) Drug Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Onychomycosis (Tinea Unguium) Drug Value Market Share Forecast by Application (2021-2025)
Table 74. Johnson and Johnson Product Offered
Table 75. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Johnson and Johnson Main Business
Table 77. Johnson and Johnson Latest Developments
Table 78. Johnson and Johnson Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 79. Qilu Pharmaceutical Product Offered
Table 80. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Qilu Pharmaceutical Main Business
Table 82. Qilu Pharmaceutical Latest Developments
Table 83. Qilu Pharmaceutical Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 84. GSK Product Offered
Table 85. GSK Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. GSK Main Business
Table 87. GSK Latest Developments
Table 88. GSK Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer Product Offered
Table 90. Pfizer Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Pfizer Main Business
Table 92. Pfizer Latest Developments
Table 93. Pfizer Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 94. Valeant Pharma Product Offered
Table 95. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. Valeant Pharma Main Business
Table 97. Valeant Pharma Latest Developments
Table 98. Valeant Pharma Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 99. Novartis Product Offered
Table 100. Novartis Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Novartis Main Business
Table 102. Novartis Latest Developments
Table 103. Novartis Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 104. Xiuzheng Pharmaceutical Product Offered
Table 105. Xiuzheng Pharmaceutical Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Xiuzheng Pharmaceutical Main Business
Table 107. Xiuzheng Pharmaceutical Latest Developments
Table 108. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Kaken Pharmaceutical Product Offered
Table 110. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Kaken Pharmaceutical Main Business
Table 112. Kaken Pharmaceutical Latest Developments
Table 113. Kaken Pharmaceutical Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 114. Letai Product Offered
Table 115. Letai Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. Letai Main Business
Table 117. Letai Latest Developments
Table 118. Letai Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
Table 119. Galderma Product Offered
Table 120. Galderma Onychomycosis (Tinea Unguium) Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. Galderma Main Business
Table 122. Galderma Latest Developments
Table 123. Galderma Basic Information, Company Total Revenue (in $ million), Onychomycosis (Tinea Unguium) Drug Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Onychomycosis (Tinea Unguium) Drug
Figure 2. Onychomycosis (Tinea Unguium) Drug Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Onychomycosis (Tinea Unguium) Drug Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Oral Medication
Figure 7. Product Picture of External Medicine
Figure 8. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type (2015-2020)
Figure 9. Global Onychomycosis (Tinea Unguium) Drug Value Market Share by Type (2015-2020)
Figure 10. Onychomycosis (Tinea Unguium) Drug Consumed in Age under 18
Figure 11. Global Onychomycosis (Tinea Unguium) Drug Market: Age under 18 (2015-2020) (K Units)
Figure 12. Global Onychomycosis (Tinea Unguium) Drug Market: Age under 18 (2015-2020) ($ Millions)
Figure 13. Onychomycosis (Tinea Unguium) Drug Consumed in Age 18-50
Figure 14. Global Onychomycosis (Tinea Unguium) Drug Market: Age 18-50 (2015-2020) (K Units)
Figure 15. Global Onychomycosis (Tinea Unguium) Drug Market: Age 18-50 (2015-2020) ($ Millions)
Figure 16. Onychomycosis (Tinea Unguium) Drug Consumed in Age above 50
Figure 17. Global Onychomycosis (Tinea Unguium) Drug Market: Age above 50 (2015-2020) (K Units)
Figure 18. Global Onychomycosis (Tinea Unguium) Drug Market: Age above 50 (2015-2020) ($ Millions)
Figure 19. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application (2015-2020)
Figure 20. Global Onychomycosis (Tinea Unguium) Drug Value Market Share by Application (2015-2020)
Figure 21. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company in 2017
Figure 22. Global Onychomycosis (Tinea Unguium) Drug Sales Market Share by Company in 2019
Figure 23. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company in 2017
Figure 24. Global Onychomycosis (Tinea Unguium) Drug Revenue Market Share by Company in 2019
Figure 25. Global Onychomycosis (Tinea Unguium) Drug Sale Price by Company in 2019
Figure 26. Global Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Regions 2015-2020
Figure 27. Global Onychomycosis (Tinea Unguium) Drug Value Market Share by Regions 2015-2020
Figure 28. Americas Onychomycosis (Tinea Unguium) Drug Consumption 2015-2020 (K Units)
Figure 29. Americas Onychomycosis (Tinea Unguium) Drug Value 2015-2020 ($ Millions)
Figure 30. APAC Onychomycosis (Tinea Unguium) Drug Consumption 2015-2020 (K Units)
Figure 31. APAC Onychomycosis (Tinea Unguium) Drug Value 2015-2020 ($ Millions)
Figure 32. Europe Onychomycosis (Tinea Unguium) Drug Consumption 2015-2020 (K Units)
Figure 33. Europe Onychomycosis (Tinea Unguium) Drug Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value 2015-2020 ($ Millions)
Figure 36. Americas Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries in 2019
Figure 37. Americas Onychomycosis (Tinea Unguium) Drug Value Market Share by Countries in 2019
Figure 38. Americas Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2019
Figure 39. Americas Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2019
Figure 40. United States Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 41. United States Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries in 2019
Figure 47. APAC Onychomycosis (Tinea Unguium) Drug Value Market Share by Regions in 2019
Figure 48. APAC Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2019
Figure 49. APAC Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2019
Figure 50. China Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 51. China Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 58. India Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 59. India Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries in 2019
Figure 63. Europe Onychomycosis (Tinea Unguium) Drug Value Market Share by Countries in 2019
Figure 64. Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2019
Figure 65. Europe Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2019
Figure 66. Germany Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 68. France Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 69. France Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 70. UK Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 71. UK Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption Market Share by Application in 2019
Figure 80. Egypt Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Onychomycosis (Tinea Unguium) Drug Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Onychomycosis (Tinea Unguium) Drug Value Growth 2015-2020 ($ Millions)
Figure 90. Global Onychomycosis (Tinea Unguium) Drug Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Onychomycosis (Tinea Unguium) Drug Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 93. Americas Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 94. APAC Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 95. APAC Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 96. Europe Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 97. Europe Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 100. United States Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 101. United States Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 102. Canada Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 103. Canada Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 104. Mexico Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 105. Mexico Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 106. Brazil Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 107. Brazil Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 108. China Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 109. China Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 110. Japan Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 111. Japan Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 112. Korea Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 113. Korea Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 116. India Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 117. India Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 118. Australia Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 119. Australia Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 120. Germany Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 121. Germany Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 122. France Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 123. France Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 124. UK Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 125. UK Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 126. Italy Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 127. Italy Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 128. Russia Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 129. Russia Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 130. Spain Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 131. Spain Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 132. Egypt Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 133. Egypt Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 134. South Africa Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 135. South Africa Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 136. Israel Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 137. Israel Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 138. Turkey Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 139. Turkey Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Onychomycosis (Tinea Unguium) Drug Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Onychomycosis (Tinea Unguium) Drug Value 2021-2025 ($ Millions)
Figure 142. Johnson and Johnson Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 143. Qilu Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 144. GSK Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 145. Pfizer Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 146. Valeant Pharma Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 147. Novartis Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 148. Xiuzheng Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 149. Kaken Pharmaceutical Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 150. Letai Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Figure 151. Galderma Onychomycosis (Tinea Unguium) Drug Market Share (2018-2020)
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets